NCT05728060

Brief Summary

To explore the fecal bile acid profile of patients with radiation enteritis, to clarify the types of bile acids that are closely related to the occurrence of radiation enteritis; to explore the interaction between fecal bile acids and intestinal flora in patients with radiation enteritis, and to lay the foundation for further elucidation of the pathogenesis of radiation enteritis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 4, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

February 14, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2023

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2024

Completed
Last Updated

July 3, 2025

Status Verified

July 1, 2025

Enrollment Period

10 months

First QC Date

February 4, 2023

Last Update Submit

July 1, 2025

Conditions

Keywords

Radiation EnteritisBile AcidGut Microbiota

Outcome Measures

Primary Outcomes (1)

  • Correlation between fecal bile acid profile and chronic radiation enteritis

    Patients' fecal bile acid profiles were analyzed by ultra-performance liquid chromatography-tandem mass spectrometry and screened for the bile acids associated with chronic radiation enteritis.

    7 months

Secondary Outcomes (1)

  • Correlation between fecal bile acid profile and intestinal microbiota in different groups.

    7 months

Study Arms (3)

chronic radiation enteritis

Non-surgically treated cervical cancer patients develop chronic radiation enteritis after radiation therapy.

No chronic radiation enteritis after radiotherapy

Patients with non-surgical cervical cancer do not develop chronic radiation enteritis after radiation therapy.

Patients with cervical cancer

Patients with cervical cancer did not undergo any treatment.

Eligibility Criteria

Age18 Years - 75 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients are from Xijing Hospital.

You may qualify if:

  • non-surgical cervical cancer patients aged 18 to 75 years who received radiotherapy;
  • Patients who can fully understand the content of informed consent for this trial and voluntarily sign the written informed consent;
  • able to receive follow-up examinations, follow-up examinations, and specimen retention on time;
  • The case group met the diagnostic criteria for chronic radiation enteritis in the "Expert Consensus on the Diagnosis and Treatment of Radiation Proctitis in China (2018 edition)"; Control group 1: Non-surgical cervical cancer patients without chronic radiation enteritis after radiotherapy; Control group 2: Patients with cervical cancer who did not receive any treatment.

You may not qualify if:

  • Presence of diseases affecting bile acid metabolism, such as hepatitis and cirrhosis of the liver from various causes, gallstones, etc;
  • Patients who have previously undergone cholecystectomy or partial resection of the intestine;
  • Taking drugs affecting bile acid metabolism due to other diseases, such as cholestyramine, anti-inflammatory and Xiaoyan lidan tablets, Danshu capsules, ursodeoxycholic acid, obeticholic acid, and proprietary Chinese medicines such as schisandrin B, Tanshinone IIA, and Yinjiazhuang;
  • Recent use of drugs that affect gastrointestinal motility;
  • Patients with moderate or severe renal impairment (blood creatinine \> 2 mg/dL or 177 mmol/L), or abnormal liver function (ALT \> 2 times the upper limit of normal value); moderate or severe chronic obstructive pulmonary disease; patients with severe hypertension, patients with cerebrovascular accidents; patients with congestive heart failure, unstable angina pectoris;
  • Patients with mental or legal disabilities;
  • Suspected or confirmed history of alcohol/substance abuse or other pathology that, in the judgment of the investigator, reduces the likelihood of enrollment or complicates enrollment;
  • Refuse to sign informed consent;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Xijing Hosipital of Digestive Disease

Xi'an, Shaanxi, 710032, China

Location

Related Publications (1)

  • Shen X, Li SB, Gao MJ, Cao JJ, Yang H, Li WW, Wei LC, Chen M, Liu JY, Shi YQ. Relationship Between Fecal Bile Acid Profile and Intestinal Microbiota in Patients With Chronic Radiation Enteritis. J Dig Dis. 2026 Jan 28. doi: 10.1111/1751-2980.70029. Online ahead of print.

Biospecimen

Retention: SAMPLES WITH DNA

Fecal samples will be stored in liquid nitrogen.

Study Officials

  • Yongquan Shi, PhD

    Xijing Hosipital of Digestive Disease

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, Clinical Professor

Study Record Dates

First Submitted

February 4, 2023

First Posted

February 14, 2023

Study Start

December 1, 2022

Primary Completion

October 1, 2023

Study Completion

March 1, 2024

Last Updated

July 3, 2025

Record last verified: 2025-07

Locations